Yu Waye Chu

Chief Tech/Sci/R&D Officer presso CYTOMX THERAPEUTICS, INC.

Patrimonio netto: 1 M $ in data 31/03/2024

56 anni

Health Technology

Consumer Services

Profilo

Yu Waye Chu ricopre la posizione di vicepresidente senior dello sviluppo clinico alla Fate Therapeutics, Inc. Ha conseguito una laurea presso l'Università di Princeton e un dottorato presso la University of Rochester School of Medicine & Dentistry.

Partecipazioni note in società pubbliche

Società	Data	Numero di azioni	Valorizzazione	Data di valutazione
FATE THERAPEUTICS, INC. 0.14%	18/04/2023	140 676 ( 0.14% )	1 M $	31/03/2024
CYTOMX THERAPEUTICS, INC. 0.04%	18/01/2024	26 250 ( 0.04% )	57 225 $	31/03/2024

Posizioni attive di Yu Waye Chu

Società	Posizione	Inizio
CYTOMX THERAPEUTICS, INC.	Chief Tech/Sci/R&D Officer	17/07/2023

Tutte le posizioni attive di Yu Waye Chu

Precedenti posizioni note di Yu Waye Chu

Società	Posizione	Fine
FATE THERAPEUTICS, INC.	Chief Tech/Sci/R&D Officer	14/07/2023
Genentech, Inc. Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.	Corporate Officer/Principal	01/04/2019

Vedi nel dettaglio l'esperienza di Yu Waye Chu

Formazione di Yu Waye Chu

Princeton University	Undergraduate Degree
University of Rochester School of Medicine & Dentistry	Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Yu Waye Chu

Relazioni

100 +

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	2
FATE THERAPEUTICS, INC.	Health Technology
CYTOMX THERAPEUTICS, INC.	Health Technology

Aziende private	1
Genentech, Inc. Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.	Health Technology